NCT05220800View on ClinicalTrials.gov

Effects of Intravenous Administered Iron in Non-anemic Iron Deficient Patients With Colorectal Cancer

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

March 1, 2024

Study Completion Date

March 1, 2029

Conditions
Iron-deficiencyColorectal Cancer
Interventions
DRUG

Iron(III)isomaltoside

Weight-dependent dosage of iron(III)isomaltoside. See group descriptions

DRUG

Placebo

Isoton saline infusion

Trial Locations (3)

4200

Slagelse Hospital, Slagelse

4600

Zealand University Hospital, Køge

8930

Regionshospitalet Randers, Randers

All Listed Sponsors
collaborator

Randers Regional Hospital

OTHER

collaborator

Slagelse Hospital

OTHER

lead

Zealand University Hospital

OTHER